Effects of venlafaxine vs lithium monotherapy on quality of life in bipolar II major depressive disorder: Findings from a double-blind randomized controlled trial
Psychiatry Research Nov 19, 2017
Lorenzo-Luaces L, et al. - The effects of antidepressant vs mood stabilizer monotherapy on quality of life ratings were investigated in bipolar II subjects during acute (12 weeks) treatment. They revealed that for bipolar II depression, quality of life could be an important secondary outcome to target and measure as a part of comparative clinical trials of pharmacotherapy.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
